A model that combines a host biomarker with a generative artificial intelligence (AI) analysis of electronic medical records ...

Skinobs’ founder and CEO Anne Charpentier examines how biomarker-based diagnostics are reshaping dermocosmetics and ...

Lunit’s new collaboration with Daiichi Sankyo integrates AI-driven digital pathology tools into oncology translational ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology ...

Lung infections like pneumonia are among the world's top killers—but diagnosing them is notoriously hard. Now, researchers at ...

A blood biomarker yet to be used in cardiac arrest care can give a clearer picture of the extent of brain damage after a ...

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...

For much of the past century, Alzheimer's disease has been one of medicine's most daunting frontiers—biologically complex, ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

Decode Age secures ₹14.48 crore in Pre Series A funding to advance ageing biology and microbiome research for healthy ...